Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 1.20557 | 1 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 1.20594 | 1 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 1.20233 | 1 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 1.18145 | 1 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 1.1851 | 1 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 1.21547 | 1 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 1.19774 | 1 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 1.18761 | 1 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 1.18937 | 1 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 1.20113 | 1 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 1.19055 | 1 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 1.19316 | 1 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 1.20286 | 1 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 1.1953 | 1 |